Search results for "MESENCHYMAL"

showing 10 items of 522 documents

Isolation and characterization of pluripotent cells from the subendocardial layer of human hearts from chronic heart failure.

2008

Purpose: Several literature reports indicated the existence of pluripotent cells residing into the heart wall, even if in vivo heart regeneration is still a poorly comprised phenomenon. Post-infarct chronic heart failure is a pathology for which heart transplant remains a key option of clinical intervention. The amount of data collected in recent years forces researchers to better characterize the properties of adult stem cells, especially for those isolated from heart. Methods: We developed a new protocol to obtain, from the subendocardial layer of post-infarct hearts explanted from chronic heart failure patients undergoing heart transplantation, populations of mesenchymal stem cells. The …

Settore BIO/16 - Anatomia Umanamesenchymal stem cells markers sub-endocardium human hearts chronic heart failure regenerative medicine differentiation
researchProduct

Isolation, characterization, differentiative properties of human mesenchymal stem cells isolated from the sub-endocardial layer of post-infarct chron…

2009

Mesenchymal stem cells (MSC) are pluripotent cells which reside in several adult organs, including heart, even if heart regeneration in vivo is still a poorly comprised phenomenon. Contrasting literature reports suggest that several efforts should be made to better characterize resident or migrating MSC populations (for both markers expression and immunogenic potential) prior to their effective use for regenerative medicine applications in heart diseases. We developed a new protocol to obtain human sub-endocardial MSC (HSE-MSC) from post-infarct hearts explanted from chronic heart failure (CHF) patients undergoing heart transplantation. We characterized HSE-MSC by immunocytochemistry (ICC) …

Settore BIO/16 - Anatomia Umanamesenchymal stem cells pluripotency self-renewal regenerative medicine human heart stemness markers cardiac markers osteogenesis adipogenesis
researchProduct

Isolation and phenotypical characterization of mesenchymal stem cells from the Wharton's jelly of pre-term human umbilical cord.

2014

Settore BIO/16 - Anatomia Umanamesenchymal stem cells pre-term human umbilical cord Wharton's jelly
researchProduct

Non-classical type I HLAs and B7 costimulators revisited: analysis of expression and immunomodulatory role in undifferentiated and differentiated MSC…

2011

Introduction. Wharton’s jelly (WJ), the main constituent of umbilical cord, emerged as a reliable and uncontroversial source of mesenchymal stem cells (MSC). WJ-MSC show unique ability in crossing lineage borders, therefore being capable to trans-ifferentiate towards mature cytotypes derived from the three germ layers. As other fetal-associated cells, WJ-MSC express several immunomodulatory molecules, essential during the initial phases of human development and for the processes linked to the tolerance of the mother to the semiallogeneic embryo. Very few data are present in literature on the maintenance of the immune privilege of the naïve cells after performing differentiation. Our previou…

Settore BIO/16 - Anatomia Umanamesenchymal stem cells umbilical cord Wharton's jelly immune modulation hepatocyte differentiation
researchProduct

Characterization of the in vitro immunomodulatory properties of mesenchymal stem cells isolated from Wharton's jelly: new actors at play

2014

Settore BIO/16 - Anatomia Umanamesenchymal stem cells wharton's jelly umbilical cord WJ-MSC
researchProduct

Wharton’s Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood–derived CD34+Cells Mimicking a Hematopoietic Niche in a Direct Cell–cel…

2018

Wharton’s jelly mesenchymal stromal cells (WJ-MSCs) have been recently exploited as a feeder layer in coculture systems to expand umbilical cord blood–hematopoietic stem/progenitor cells (UCB-HSPCs). Here, we investigated the role of WJ-MSCs in supporting ex vivo UCB-HSPC expansion either when cultured in direct contact (DC) with WJ-MSCs or separated by a transwell system or in the presence of WJ-MSC–conditioned medium. We found, in short-term culture, a greater degree of expansion of UCB-CD34+cells in a DC system (15.7 ± 4.1-fold increase) with respect to the other conditions. Moreover, in DC, we evidenced two different CD34+cell populations (one floating and one adherent to WJ-MSCs) with …

Settore BIO/17 - Istologia0301 basic medicineStromal cellextracellular matrixCell Culture TechniquesBiomedical EngineeringCD34lcsh:MedicineAntigens CD34Brief Communication03 medical and health sciencesWharton's jellyHumansWharton JellyProgenitor cellCoculture TechniqueColony-forming unitTransplantationChemistrylcsh:RMesenchymal stem cellMesenchymal Stem CellsCell DifferentiationHematopoietic Stem CellCell BiologyHematopoietic Stem CellsFetal BloodADP-ribosyl Cyclase 1Coculture TechniquesCell biologysecretomeMesenchymal Stem Cell030104 developmental biologyhematopoietic nicheCord bloodhematopoietic stem and progenitor cell expansionWharton’s jelly mesenchymal stromal cellWharton’s jelly mesenchymal stromal cellsCell Culture TechniqueHumanHoming (hematopoietic)Cell Transplantation
researchProduct

New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells.

2013

Cardiomyopathies are still the first cause of death in the world. The identification of resident stem cells, comprising those derived from sub-endocardial stroma, suggests the possible self regeneration of the heart under autocrine/paracrine modulation in the cardiac microenvironment. Nevertheless, because of the limited in vivo regeneration potential of damaged cardiac tissue, the use of drugs and ultimately cardiac transplantation remain the common treatments of heart diseases and defects. The differentiative potential of embryonic and mesenchymal stem cells (MSCs) derived from different tissues (such as bone marrow and adipose tissue) was extensively explored in cell therapy for regenera…

Settore BIO/17 - IstologiaImmune modulationCardiologyMedicine (miscellaneous)Clinical uses of mesenchymal stem cellsHeart failureBiologyRegenerative MedicineRegenerative medicineWharton's jellyHumansWharton JellyTissue repairMesenchymal stem cellStem cell transplantation for articular cartilage repairSettore BIO/16 - Anatomia UmanaWharton's jellyRegeneration (biology)Mesenchymal stem cellMesenchymal Stem CellsGeneral MedicineHeart failure; Immune modulation; Mesenchymal stem cells; Regenerative medicine; Tissue repair; Wharton's jellyTransplantationCardiovascular DiseasesImmunologyCancer researchStem cell
researchProduct

Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications

2022

Chondropathies are increasing worldwide, but effective treatments are currently lacking. Mesenchymal stromal cell (MSCs) transplantation represents a promising approach to counteract the degenerative and inflammatory environment characterizing those pathologies, such as osteoarthritis (OA) and rheumatoid arthritis (RA). Umbilical cord- (UC-) MSCs gained increasing interest due to their multilineage differentiation potential, immunomodulatory, and anti-inflammatory properties as well as higher proliferation rates, abundant supply along with no risks for the donor compared to adult MSCs. In addition, UC-MSCs are physiologically adapted to survive in an ischemic and nutrient-poor environment a…

Settore BIO/17 - IstologiaReview ArticleCell Biologymesenchymal stromal cells stem cells cartilage regenerative medicien tissue engineering immune modulationMolecular BiologyInternal medicineRC31-1245Stem Cells International
researchProduct

Mesenchymal Stromal cells from Wharton's jelly (MSCs): coupling their hidden differentiative program to their frank immunomodulatory phenotype.

2018

No abstract

Settore BIO/17 - IstologiaWharton's jelly mesenchymal stromal cells differentiation immunomodulation umbilical cord stem cells
researchProduct

The Immunomodulatory Features of Mesenchymal Stromal Cells Derived from Wharton’s Jelly, Amniotic Membrane, and Chorionic Villi In Vitro and In Vivo …

2016

This chapter focuses on the immunomodulatory properties of placental mesenchymal stromal cells (MSCs) derived from the amniotic membrane, umbilical cord, and chorionic villi. Within the amniotic membrane (AM), we discuss the immunomodulatory properties of the two main cell populations that can be isolated from AM: human amniotic mesenchymal stromal cells (hAMSCs) and human amniotic epithelial cells (hAECs). Within the umbilical cord, several compartments have been described, including the amniotic compartment, the Wharton’s jelly (WJ) compartment, and the vascular and perivascular compartment, but herein attention is focused on the properties of human WJ MSCs (hWJMSCs). Since different isol…

Settore BIO/17 - IstologiaWharton’s JellyUmbilical cord Wharton's jelly placenta mesenchymal stromal cells stem cells chorionic villi amniotic membrane regenerative medicine differentiation immeune modulationSettore BIO/16 - Anatomia UmanaSettore BIO/13 - BIOLOGIA APPLICATA
researchProduct